Cardiac Sarcoidosis (FDG PET)

Quick Answer

FDG PET detects active inflammation in cardiac sarcoidosis — but only if physiologic myocardial glucose uptake is suppressed by careful dietary preparation (high-fat, very-low-carbohydrate meals then fasting, ± heparin per protocol). It is read against a rest perfusion study: focal or focal-on-diffuse FDG uptake matching a perfusion defect (perfusion–metabolism mismatch) is the hallmark of active disease. Diffuse homogeneous uptake almost always means failed suppression, not disease — the single commonest cause of an uninterpretable study.

Background & Clinical Importance

Cardiac sarcoidosis causes conduction disease (AV block), ventricular arrhythmia, and heart failure, and is frequently underdiagnosed — sometimes presenting as unexplained heart block in a young/middle-aged patient. Unlike scar-focused cardiac MRI (late gadolinium), FDG PET assesses disease activity, making it central to treatment decisions and follow-up; the two modalities are complementary (MRI for scar/fibrosis, PET for active inflammation).

Pathophysiology

Sarcoidosis produces non-caseating granulomas; activated macrophages in active lesions are highly glycolytic and avidly take up FDG. The imaging challenge is that normal myocardium also uses glucose, so unless myocardial glucose metabolism is suppressed, physiologic uptake masks the inflammatory signal.

The Critical Step: Myocardial Suppression

Preparation shifts myocardial metabolism to free fatty acids so that only inflammatory cells light up:

• High-fat, very-low/no-carbohydrate meals for ~1–2 days before, then a prolonged fast (protocols vary; a common regimen is ≥2 low-carb high-fat meals then ≥12 h fast).
• Unfractionated heparin before injection in some protocols (lipolysis raises circulating free fatty acids).
• Avoid glucose-containing IV fluids; manage diabetics carefully.

Inadequate suppression is the single most common cause of an uninterpretable study.

Protocol

Rest perfusion imaging (SPECT or PET) + FDG PET, ideally whole-body FDG to detect extracardiac sarcoid and identify an accessible biopsy target (mediastinal/hilar nodes are easier than myocardium).

Interpretation Patterns

Read FDG against the rest perfusion study:

Serial scans track response to immunosuppression — falling FDG intensity/extent indicates response; persistent/increasing uptake prompts escalation.

Interpretation & Decision

Confirm dietary-prep adherence before reading. A perfusion–metabolism mismatch (reduced perfusion + focal FDG) indicates active, treatable inflammation; a matched defect without FDG is scar. Diffuse homogeneous myocardial uptake should be called inadequate suppression, not disease. Maintain consistent preparation across serial studies for valid comparison.

Differential Diagnosis

Failed suppression (physiologic uptake), lateral-wall physiologic variant, idiopathic giant-cell myocarditis, other inflammatory/infectious myocarditis, and ischemic scar.

Reporting Checklist

• Verify dietary preparation and state suppression adequacy.
• Report FDG pattern vs perfusion (mismatch = active; matched without FDG = scar).
• Note extracardiac disease and a suggested biopsy target.
• For follow-up, compare like-prepared serial studies.

Common Pitfalls

• Diffuse physiologic uptake misread as disease (failed suppression).
• Lateral-wall physiologic uptake variant over-called.
• Reading FDG without the paired perfusion study.
• Inconsistent preparation invalidating serial comparison.

Board Pearls

FDG PET detects active inflammation in cardiac sarcoidosis, but only if physiologic myocardial glucose uptake is suppressed by dietary prep (high-fat/very-low-carb, then fast, ± heparin). Read it against a rest perfusion study: focal or focal-on-diffuse FDG matching a perfusion defect (perfusion–metabolism mismatch) is the hallmark of active disease.

Diffuse homogeneous uptake almost always means failed suppression, not disease — the single commonest cause of an uninterpretable study. Interpretability lives and dies by dietary prep — verify adherence before reading, and keep preparation consistent across serial scans.

PET assesses activity; MRI late-gadolinium assesses scar — they are complementary. A matched perfusion defect without FDG is scar/fibrosis (not active). Whole-body FDG can find an easier extracardiac biopsy target (hilar/mediastinal nodes). Watch the lateral-wall physiologic variant.

Related Pages

• Tracer: FDG; disease: Systemic sarcoidosis; related: nuclear cardiology, perfusion imaging.

Figure / Diagram Suggestions

• A suppression mechanism cartoon (FFA shift; macrophage FDG uptake).
• A perfusion–metabolism mismatch teaching matrix (active vs scar vs failed-suppression).
• A dietary-prep timeline (high-fat/low-carb → fast → ± heparin).

Self-Check